Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akorn, Inc. (AKRX)

« Back to company index

AKRX Chatter Timeline

Stock Ticker for AKRX

Most Active Tweeters for AKRX

UserTweets
@ConsumerFeed 3
@AmericanBanking 3
@TickerReport 2
@EnterpriseLeade 2
@TheMarketsDaily 2

Recent Tweets for AKRX

StockTipRobot @StockTipRobot
After crunching the numbers, I advise you drop Akorn $AKRX #Advice
July 15th 2019, 8:07pm
WeekHerald @WeekHerald
Akorn $AKRX Downgraded to Hold at BidaskClub https://t.co/3kIMU6arXr
July 15th 2019, 5:07am
TickerReport @TickerReport
Akorn $AKRX Downgraded to Hold at BidaskClub https://t.co/9pPVPqTps1
July 15th 2019, 5:07am
ConsumerFeed @ConsumerFeed
$172.41 Million in Sales Expected for Akorn, Inc. $AKRX This Quarter https://t.co/CkhxfQWVnq
July 14th 2019, 5:07pm
TekATL3 @TekATL3
This one possible testing flag break line ,see if she can bounce for next leg. $AKRX
July 14th 2019, 1:07pm
stocknewstimes @stocknewstimes
BidaskClub Lowers Akorn $AKRX to Hold https://t.co/gI5AnG2Yfx
July 14th 2019, 8:07am
TranscriptDaily @TranscriptDaily
BidaskClub Lowers Akorn $AKRX to Hold https://t.co/VS0DYpxR6J
July 14th 2019, 8:07am
TheMarketsDaily @TheMarketsDaily
BidaskClub Lowers Akorn $AKRX to Hold https://t.co/DkNsfk8ALg
July 14th 2019, 8:07am
ZolmaxNews @ZolmaxNews
Akorn $AKRX Upgraded to Buy at Zacks Investment Research https://t.co/7IZ45VMTRX
July 13th 2019, 6:07am
ConsumerFeed @ConsumerFeed
Akorn $AKRX Rating Lowered to Hold at BidaskClub https://t.co/D6RWnUqTnP
July 13th 2019, 5:07am
AmericanBanking @AmericanBanking
Akorn, Inc. $AKRX Given Average Rating of “Hold” by Analysts https://t.co/9ep98PI4kx #stocks
July 13th 2019, 2:07am
TekATL3 @TekATL3
$AKRX May share, she got to 5.40 https://t.co/sUfkzPigoV
July 12th 2019, 11:07pm
IRAMarketReport @IRAMarketReport
Zacks: Brokerages Expect Akorn, Inc. $AKRX Will Announce Quarterly Sales of $172.41 Million https://t.co/wPqfP2QjlI #markets
July 12th 2019, 6:07pm
chaffeybreeze @chaffeybreeze
Zacks: Brokerages Expect Akorn, Inc. $AKRX Will Announce Quarterly Sales of $172.41 Million https://t.co/jLPFRsLCSB #stocks
July 12th 2019, 6:07pm
ConsumerFeed @ConsumerFeed
Zacks: Brokerages Anticipate Akorn, Inc. $AKRX to Post -$0.06 Earnings Per Share https://t.co/At5MmWzdin
July 12th 2019, 6:07pm
dakotafinancial @dakotafinancial
Akorn $AKRX Downgraded to “Hold” at BidaskClub https://t.co/SQ1PFKsqvL
July 12th 2019, 12:07pm
registrarjourn @registrarjourn
Akorn $AKRX Rating Increased to Buy at Zacks Investment Research https://t.co/F6cdY2a9VV
July 12th 2019, 9:07am
EnterpriseLeade @EnterpriseLeade
Akorn $AKRX Rating Increased to Buy at Zacks Investment Research https://t.co/ku2E9vf0uB
July 12th 2019, 9:07am
dispatchtribune @dispatchtribune
Akorn $AKRX Raised to “Buy” at Zacks Investment Research https://t.co/KV6uW33rEk
July 12th 2019, 9:07am
HottestStockNow @HottestStockNow
Upcoming Key Date for $AKRX Shareholders https://t.co/4Jz3m57HiN
July 11th 2019, 7:07pm
newswithvalue @newswithvalue
$AKRX: Akorn to Report Second Quarter 2019 Financial Results and Host …: https://t.co/80QS2SUH77
July 11th 2019, 5:07pm
macondailynews @macondailynews
Akorn $AKRX Stock Rating Upgraded by Zacks Investment Research https://t.co/hXl5lt1jj8
July 11th 2019, 4:07pm
VisualStockRSRC @VisualStockRSRC
$AKRX - Akorn to Report Second Quarter 2019 Financial Results and Host Conference Call https://t.co/6C5XRV9S0y
July 11th 2019, 4:07pm
macondailynews @macondailynews
-$0.06 Earnings Per Share Expected for Akorn, Inc. $AKRX This Quarter https://t.co/gS1358ddM2
July 10th 2019, 8:07am
TheMarketsDaily @TheMarketsDaily
-$0.06 Earnings Per Share Expected for Akorn, Inc. $AKRX This Quarter https://t.co/pTtjAmqv4g
July 10th 2019, 8:07am
TickerReport @TickerReport
Akorn $AKRX Upgraded to “Buy” by Zacks Investment Research https://t.co/Ob0K6nQ5qy
July 10th 2019, 5:07am
finzine @finzine
$FRE $AKRX Quality Failures at Generic Drug Maker Put Patients at Risk, FDA Warns via https://t.co/dU2ohMsCEH
July 9th 2019, 5:07pm
VetTrader @VetTrader
RT @danshep55: $AKRX gets fda warning letter from NJ plant inspection
July 9th 2019, 10:07am
EliteDayTraders @EliteDayTraders
$AKRX received fda warning letter
July 9th 2019, 10:07am
danshep55 @danshep55
$AKRX gets fda warning letter from NJ plant inspection
July 9th 2019, 9:07am
FastestSignals @FastestSignals
SELL $AKRX - $AKRX GET FDA WARNING LETTER FOR NEW JERSEY PLANT INSPECTION
July 9th 2019, 9:07am
AmericanBanking @AmericanBanking
$172.41 Million in Sales Expected for Akorn, Inc. $AKRX This Quarter https://t.co/7sh2wzTYKg #stocks
July 7th 2019, 2:07am
ChartMill @ChartMill
$AKRX: The EPS growth is accelerating: in the next 2 years the growth will be better than in the last years.… https://t.co/RfcsfPgpjp
July 6th 2019, 12:07am
TopStockAlerts1 @TopStockAlerts1
$AKRX has a history of nice spikes stay tuned for more! https://t.co/ZKx6HyHoXo
July 5th 2019, 10:07pm
AmericanBanking @AmericanBanking
Akorn, Inc. $AKRX Expected to Post Earnings of -$0.06 Per Share https://t.co/zdniiv8DcX #stocks
July 5th 2019, 4:07am
Easy_Money_weee @Easy_Money_weee
$AKRX $5.31 nice chart been on my radar for a while.
July 3rd 2019, 11:07am
ThisLincolnian @ThisLincolnian
Akorn $AKRX Upgraded at BidaskClub https://t.co/ohNrlIxTt5
July 3rd 2019, 2:07am
registrarjourn @registrarjourn
Akorn $AKRX Upgraded at BidaskClub https://t.co/INajUa2BEP
July 3rd 2019, 2:07am
EnterpriseLeade @EnterpriseLeade
Akorn $AKRX Upgraded at BidaskClub https://t.co/tIhO2OCWiA
July 3rd 2019, 2:07am
dakotafinancial @dakotafinancial
Akorn $AKRX Rating Increased to Buy at BidaskClub https://t.co/pVyaNhbJ8p
July 1st 2019, 1:07am
TickerReport @TickerReport
Akorn $AKRX Rating Increased to Buy at BidaskClub https://t.co/kasjLOVQuR
July 1st 2019, 1:07am
HottestStockNow @HottestStockNow
$AKRX launches its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspension, 0.5% https://t.co/4Jz3m57HiN
June 29th 2019, 10:06am
Tickeron @Tickeron
A.I.dvisor made a bullish call on $AKRX, netting in a 23.50% gain over 2 weeks https://t.co/kqpHVziViC https://t.co/Hld94bzbeM
June 29th 2019, 3:06am
Easy_Money_weee @Easy_Money_weee
$AKRX getting hot.
June 28th 2019, 11:06am
Gambiste1 @Gambiste1
RT @ToothFrank: Akorn ( $AKRX ) said Friday it has launched its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspension, 0.5…
June 28th 2019, 9:06am
ToothFrank @ToothFrank
Akorn ( $AKRX ) said Friday it has launched its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspens… https://t.co/yjmTTirlBH
June 28th 2019, 8:06am
VisualStockRSRC @VisualStockRSRC
$AKRX - Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5% https://t.co/ROJDjwGqoE
June 28th 2019, 7:06am
ProTradersNews @ProTradersNews
$AKRX: Did Hedge Funds Drop The Ball On Akorn, Inc. (AKRX) ?: https://t.co/rmR9nwE9VU
June 27th 2019, 11:06am
StockConsultant @StockConsultant
$AKRX Akorn stock with a nice breakout follow through, volume +39% normal, analysis https://t.co/dsMIxFJbOM… https://t.co/29N6N7ocrH
June 27th 2019, 11:06am
TekATL3 @TekATL3
$AKRX beaut breaking higher
June 27th 2019, 10:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.